Eight recent, attributable targets were reviewed for this analysis. Piper Sandler sits at the cautious end with a $13 target and a Neutral rating, while Needham's $45 target anchors the bullish end. In between are RBC Capital at $22 (Outperform), Jefferies at $26 (Buy), Goldman Sachs at $31 (Buy), J.P. Morgan at $32 (Overweight), and Bank of America at $34 (Buy), with a separate $21 initiation rounding out the group. Averaging these eight figures produces roughly $28, the central target used here.
The dispersion is striking and reflects genuine disagreement rather than a settled view. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. Aggregate estimates from data providers cluster anywhere from the mid-$20s to the mid-$30s depending on which analysts and time windows are included — a reminder that the "average analyst price target" is sensitive to methodology. Analysts have repeatedly lowered targets through late 2026: RBC Capital cut its target from $31 to $26 and then to $22, while Piper Sandler trimmed its figure from $20 to $13. The bullish view rests on expanding demand across launched effects, precision strike, and maritime autonomy, plus what Jefferies describes as a roughly 50% discount to peers. The cautious view centers on limited revenue visibility.
The stock trades near $12.13, giving it a market value of roughly $840 million. Reaching $28 requires about 131% upside — a very large move that would require a durable re-rating, not a routine rally. The shares have already collapsed from a 52-week high near $42.34, meaning any path to $28 must first repair substantial technical and sentiment damage. With trailing revenue around $697 million and a forward P/E near 17, the stock no longer carries the premium valuation of its post-listing peak, but it also lacks the momentum that drove it there.
Demand for autonomous and attritable systems remains a genuine secular tailwind for AVEX. Management has raised 2026 guidance twice, reflecting roughly $600 million to $620 million in expected revenue and $88 million to $94.5 million in adjusted EBITDA. The acquisition of BlackSea expanded its maritime-autonomy exposure. If revenue visibility improves and contract awards accelerate, the valuation gap cited by Jefferies and the supportive ratings from Goldman Sachs, J.P. Morgan, and Bank of America could begin to close.
The clearest obstacle is revenue visibility, which RBC Capital flagged as a persistent headwind to sentiment even while maintaining an Outperform rating. Government budget cycles, program timing, and potential shifts in defense-spending priorities can delay awards. The stock's sharp post-IPO drawdown also reflects investor skepticism that must be overcome. If near-term results or guidance disappoint, further target reductions — as Piper Sandler has already signaled — could push the consensus lower and keep the shares rangebound well below $28.
The 52-week range of roughly $8.95 to $42.34 frames the technical picture. The $9 area, near the 52-week low, is the most important downside reference, while the low-to-mid teens have served as a stabilization zone in late 2026. On the upside, reclaiming the $20 level — where several reduced targets sit — would mark the first meaningful sign of structural repair, followed by the mid-$20s. The stock remains in a deep long-term downtrend from its debut high, so any sustained move toward $28 would require clearing multiple layers of prior resistance.
Analyst price targets generally reflect a roughly 12-month research horizon, though individual firms do not always state this explicitly and the wide target range here suggests differing assumptions about growth, margins, and re-rating potential. Investors should watch upcoming earnings and guidance updates, contract awards, any further analyst revisions, and broader defense-budget developments in Washington. Given how quickly targets have been cut, the direction of revisions may matter as much as the absolute figures.
Tickeron's AI Daily Buy/Sell Signals have become a regular part of my routine for monitoring high-volatility names like AVEX. The tool applies artificial intelligence to scan thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting market conditions and technical behavior. For a stock with this kind of price action, it helps surface potential momentum changes more efficiently than reviewing charts manually, allowing me to cross-check ideas and stay alert to developing setups without replacing my own analysis.
The $28 central target — the mean of eight recent analyst price targets — implies roughly 131% upside from a price near $12.13. That is a very large move, and it rests on a re-rating that only improving revenue visibility and accelerating defense demand would plausibly support. The bullish case is grounded in real UAS and precision-strike tailwinds and a discount to peers, while the bearish case points to limited visibility and a stock still recovering from a steep drawdown. The $13-to-$45 analyst range shows that no single number commands consensus. Investors should treat $28 as a mathematical midpoint of divergent views, not a forecast, and monitor earnings, guidance, contract flow, and further target revisions before drawing conclusions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Oscillator for AVEX moved out of oversold territory on October 27, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 1 similar instances when the indicator left oversold territory. In 1 of the 1 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 4 of 5 cases where AVEX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.
The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on AVEX as a result. In 5 of 7 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.
The Moving Average Convergence Divergence (MACD) for AVEX just turned positive on November 10, 2026. Looking at past instances where AVEX's MACD turned positive, the stock continued to rise in 2 of 3 cases over the following month. The odds of a continued upward trend are 67%.
Following a +13.73% 3-day Advance, the price is estimated to grow further. Considering data from situations where AVEX advanced for three days, in 22 of 28 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
AVEX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVEX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for AVEX entered a downward trend on October 30, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 42 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-1.322) is normal, around the industry mean (5.050). P/E Ratio (17.394) is within average values for comparable stocks, (17.247). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (1.310) is also within normal values, averaging (18.367).
The Tickeron SMR rating for this company is 75 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 83 (best 1 - 100 worst), indicating slightly worse than average price growth. AVEX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVEX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry AerospaceDefense